0001493152-24-009575.txt : 20240311 0001493152-24-009575.hdr.sgml : 20240311 20240311161532 ACCESSION NUMBER: 0001493152-24-009575 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240307 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tharimmune, Inc. CENTRAL INDEX KEY: 0001861657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 842642541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41210 FILM NUMBER: 24738211 BUSINESS ADDRESS: STREET 1: 1200 ROUTE 22 EAST CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 302-743-2995 MAIL ADDRESS: STREET 1: 245 MAIN STREET STREET 2: SUITE 204 CITY: CHESTER STATE: NJ ZIP: 07930 FORMER COMPANY: FORMER CONFORMED NAME: Tharimmune, Inc DATE OF NAME CHANGE: 20230925 FORMER COMPANY: FORMER CONFORMED NAME: Hillstream BioPharma Inc. DATE OF NAME CHANGE: 20210511 8-K 1 form8-k.htm
false --12-31 0001861657 0001861657 2024-03-07 2024-03-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) March 7, 2024

 

THARIMMUNE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41210   84-2642541
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I. R. S. Employer
Identification No.)

 

1200 Route 22 East, Suite 2000

Bridgewater, NJ 08807

(Address of principal executive offices, including zip code)

 

(908) 955-3140

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, $0.0001 par value   THAR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 
 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On March 7, 2024, the board of directors (the “Board”) of Tharimmune, Inc. (the “Company”) approved an amendment (the “Amendment”) to the Company’s Bylaws (the “Bylaws”).

 

The Amendment amends and restates in its entirety Article II, Section 2.6 of the Bylaws to lower the quorum requirement for stockholder meetings from requiring the holders of a majority of the Company’s stock issued and outstanding and entitled to vote to be present in person or represented by proxy to one-third of the holders of the Company’s stock issued and outstanding and entitled to vote to be present in person or represented by proxy.

 

The foregoing description of the Amendment set forth herein does not purport to be complete and is qualified in its entirety by the full text of the Amendment which is attached hereto as Exhibit 3.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
3.1   Amendment to the Bylaws of Tharimmune, Inc.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 11, 2024 Tharimmune, Inc.
   
  /s/ Randy Milby
  Randy Milby
  Chief Executive Officer

 

 

 

 

EX-3.1 2 ex3-1.htm

 

Exhibit 3.1

 

AMENDMENT NO. 1 TO THE BYLAWS

OF

THARIMMUNE, INC.

a Delaware Corporation

 

Pursuant to the resolutions of the Board of Directors (the “Board”) of Tharimmune, Inc., a Delaware corporation (the “Corporation”) adopted on March 7, 2024 and in accordance with the authority provided to the directors pursuant to Article IX of the Company’s Bylaws (the “Bylaws”):

 

1. Article II, Section 2.6 of the Bylaws is amended and restated in its entirety as follows as of March 7, 2024 (the “Effective Time”):

 

Section 2.6. Quorum. Unless otherwise provided by law, the certificate of incorporation or these Bylaws, the holders of thirty-three and one-third percent (33 and 1/3%) in voting power of the stock issued and outstanding and entitled to vote, present in person, or by remote communication, if applicable, or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders. If, however, a quorum is not present or represented at any meeting of the stockholders, then either (i) the chairperson of the meeting or (ii) a majority in voting power of the stockholders entitled to vote at the meeting, present in person, or by remote communication, if applicable, or represented by proxy, shall have power to adjourn the meeting to another place (if any), date or time.”

 

C E R T I F I C A T E O F S E C R E T A R Y

 

I, the undersigned, do hereby certify:

 

1. That I am the duly elected and acting secretary of Tharimune, Inc., a Delaware corporation; and

 

2. That the foregoing Amendment No. 1 to the Bylaws, was duly adopted by the Board of Directors of said Company on March 7, 2024.

 

IN WITNESS WHEREOF, I have hereunto subscribed my name and affixed the seal of said Company as of March 7, 2024.

 

  /s/ Randy Milby
Randy Milby

 

 

 

 

EX-101.SCH 3 thar-20240307.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 thar-20240307_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 thar-20240307_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Mar. 07, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 07, 2024
Current Fiscal Year End Date --12-31
Entity File Number 001-41210
Entity Registrant Name THARIMMUNE, INC.
Entity Central Index Key 0001861657
Entity Tax Identification Number 84-2642541
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1200 Route 22 East
Entity Address, Address Line Two Suite 2000
Entity Address, City or Town Bridgewater
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08807
City Area Code (908)
Local Phone Number 955-3140
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, $0.0001 par value
Trading Symbol THAR
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 25 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://tharimmune.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm thar-20240307.xsd thar-20240307_lab.xml thar-20240307_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "THAR", "nsuri": "http://tharimmune.com/20240307", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "thar-20240307.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "thar-20240307_lab.xml" ] }, "presentationLink": { "local": [ "thar-20240307_pre.xml" ] } }, "keyStandard": 25, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 25 }, "report": { "R1": { "role": "http://tharimmune.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-03-07", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-03-07", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://tharimmune.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001493152-24-009575-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-009575-xbrl.zip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end XML 16 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001861657 2024-03-07 2024-03-07 iso4217:USD shares iso4217:USD shares false --12-31 0001861657 8-K 2024-03-07 THARIMMUNE, INC. DE 001-41210 84-2642541 1200 Route 22 East Suite 2000 Bridgewater NJ 08807 (908) 955-3140 false false false false Common stock, $0.0001 par value THAR NASDAQ true false